Compare ARK Genomic Revolution ETF (ARKG) vs Gemini Space Station Inc (GEMI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Gemini Space Station Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Gemini Space Station Inc trades at $4.29 (market cap $544.29M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | GEMI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $32.52 |
52-Week Low | $23.09 | $3.91 |
Market Cap | — | $544.29M |
Enterprise Value | — | $534.28M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Gemini Space Station (GEMI) trades at $4.31, up 1.41% on the day, but remains in a bearish technical trend with key support at $4. The company reported a net loss of $582.81 million in 2025 on revenue of $179.57 million, with negative profit margins and cash flow from operations. Recent news includes a $100 million investment from Winklevoss Capital but also multiple securities class action lawsuits filed against the company.
The outlook is highly speculative. The capital infusion provides near-term funding, but persistent losses, negative cash flow, and legal challenges present significant risks. Analyst consensus is mixed with a $5.88 price target, suggesting potential upside if the company can execute its turnaround, but the fundamental picture remains weak.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →
